Cargando…

Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects

BACKGROUND: Exposure to perfluorinated alkylate substances (PFAS) is associated with harmful effects on human health, including developmental immunotoxicity. This outcome was chosen as the critical effect by the European Food Safety Authority (EFSA), which calculated a new joint reference dose for f...

Descripción completa

Detalles Bibliográficos
Autores principales: Budtz-Jørgensen, Esben, Grandjean, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163703/
https://www.ncbi.nlm.nih.gov/pubmed/37147704
http://dx.doi.org/10.1186/s12940-023-00985-w
_version_ 1785037937775214592
author Budtz-Jørgensen, Esben
Grandjean, Philippe
author_facet Budtz-Jørgensen, Esben
Grandjean, Philippe
author_sort Budtz-Jørgensen, Esben
collection PubMed
description BACKGROUND: Exposure to perfluorinated alkylate substances (PFAS) is associated with harmful effects on human health, including developmental immunotoxicity. This outcome was chosen as the critical effect by the European Food Safety Authority (EFSA), which calculated a new joint reference dose for four PFAS using a Benchmark Dose (BMD) analysis of a study of 1-year old children. However, the U.S. Environmental Protection Agency (EPA) recently proposed much lower exposure limits. METHODS: We explored the BMD methodology for summary and individual data and compared the results with and without grouping for two data sets available. We compared the performance of different dose-response models including a hockey-stick model and a piecewise linear model. We considered different ways of testing the assumption of equal weight-based toxicity of the four PFAS and evaluated more flexible models with exposure indices allowing for differences in toxicity. RESULTS: Results relying on full and decile-based data were in good accordance. However, BMD results for the larger study were lower than observed by EFSA for the smaller study. EFSA derived a lower confidence limit for the BMD of 17.5 ng/mL for the sum of serum-PFAS concentration, while similar calculations in the larger cohort yielded values of about 1.5 ng/mL. As the assumption of equal weight-based toxicity of the four PFAS seems questionable, we confirmed dose-dependencies that allowed potency differences between PFAS. We also found that models linear in the parameters for the BMD analysis showed superior coverage probabilities. In particular, we found the piecewise linear model to be useful for Benchmark analysis. CONCLUSIONS: Both data sets considered could be analyzed on a decile basis without important bias or loss of power. The larger study showed substantially lower BMD results, both for individual PFAS and for joint exposures. Overall, EFSA’s proposed tolerable exposure limit appears too high, while the EPA proposal is in better accordance with the results.
format Online
Article
Text
id pubmed-10163703
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101637032023-05-07 Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects Budtz-Jørgensen, Esben Grandjean, Philippe Environ Health Research BACKGROUND: Exposure to perfluorinated alkylate substances (PFAS) is associated with harmful effects on human health, including developmental immunotoxicity. This outcome was chosen as the critical effect by the European Food Safety Authority (EFSA), which calculated a new joint reference dose for four PFAS using a Benchmark Dose (BMD) analysis of a study of 1-year old children. However, the U.S. Environmental Protection Agency (EPA) recently proposed much lower exposure limits. METHODS: We explored the BMD methodology for summary and individual data and compared the results with and without grouping for two data sets available. We compared the performance of different dose-response models including a hockey-stick model and a piecewise linear model. We considered different ways of testing the assumption of equal weight-based toxicity of the four PFAS and evaluated more flexible models with exposure indices allowing for differences in toxicity. RESULTS: Results relying on full and decile-based data were in good accordance. However, BMD results for the larger study were lower than observed by EFSA for the smaller study. EFSA derived a lower confidence limit for the BMD of 17.5 ng/mL for the sum of serum-PFAS concentration, while similar calculations in the larger cohort yielded values of about 1.5 ng/mL. As the assumption of equal weight-based toxicity of the four PFAS seems questionable, we confirmed dose-dependencies that allowed potency differences between PFAS. We also found that models linear in the parameters for the BMD analysis showed superior coverage probabilities. In particular, we found the piecewise linear model to be useful for Benchmark analysis. CONCLUSIONS: Both data sets considered could be analyzed on a decile basis without important bias or loss of power. The larger study showed substantially lower BMD results, both for individual PFAS and for joint exposures. Overall, EFSA’s proposed tolerable exposure limit appears too high, while the EPA proposal is in better accordance with the results. BioMed Central 2023-05-06 /pmc/articles/PMC10163703/ /pubmed/37147704 http://dx.doi.org/10.1186/s12940-023-00985-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Budtz-Jørgensen, Esben
Grandjean, Philippe
Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects
title Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects
title_full Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects
title_fullStr Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects
title_full_unstemmed Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects
title_short Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects
title_sort benchmark dose calculations for pfas exposure based on two data sets on immunotoxic effects
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163703/
https://www.ncbi.nlm.nih.gov/pubmed/37147704
http://dx.doi.org/10.1186/s12940-023-00985-w
work_keys_str_mv AT budtzjørgensenesben benchmarkdosecalculationsforpfasexposurebasedontwodatasetsonimmunotoxiceffects
AT grandjeanphilippe benchmarkdosecalculationsforpfasexposurebasedontwodatasetsonimmunotoxiceffects